Data includes aggregated resistance rates for isolates (includes intermediate resistance) from blood and cerebrospinal fluid (i.e., invasive) from inpatients of all ages. Because of differences in scope of collections and testing methods, caution should be exercised in comparing across countries. For more details see methodology
Country boundaries/designations do not represent CDDEP opinion concerning the legal status of any country, territory, city, or area of its authorities, or concerning the delimitation of its frontiers or boundaries.
Cephalosporins (3rd gen)